• HOME
  •  > 
  • 基礎医学
  •  > 
  • 免疫/血清
  •  >  エンドトキシン・自然免疫研究　17　エンドトキシン・自然免疫の展開:新しい機序、診断、応用

エンドトキシン・自然免疫研究　17　エンドトキシン・自然免疫の展開:新しい機序、診断、応用

出版社： 医学図書出版
著者：
発行日： 2014-11-25
分野： 基礎医学  >  免疫/血清
ISBN： 9784865170863
電子書籍版： 2014-11-25 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,200 円(税込)

購入する

目次

  • エンドトキシン・自然免疫研究　17
    エンドトキシン・自然免疫の展開：新しい機序、診断、応用

    ―目次―

    第1章　シンポジウム「エンドトキシン吸着療法の20年と今後」
    第2章　ワークショップ1「敗血症の診断と現状」
    第3章　ワークショップ2「最新の自然免疫研究」
    第4章　平成25年度日本エンドトキシン・
    　　　　自然免疫研究会奨励賞・優秀賞
    第5章　ランチョンセミナー「トレミキシン開発の歴史」
    第6章　一般演題

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

P.6 掲載の参考文献
1) Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group : Polymyxin B hemoperfusion in clinical practice : the picture from an unbound collaborative registry. Blood Purif 37 : S22-25, 2014
 
2) Ronco C : Endotoxin removal : history of a mission. Blood Purif 37 : S5-8, 2014
 
3) Ebihara I, Nakamura T, Shimada N, et al. : Effect of hemoperfusion with polymyxin B-immobilized fiber on plasma endothelin-1 and endothelin-1 mRNA in monocytes from patients with sepsis. Am J Kidney Dis 32 : 953-961, 1998
PubMed
4) Nakamura T, Ebihara I, Shimada N, et al. : Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock : effect of fiber-immobilized polymyxin B treatment. Am J Med Sci 316 : 355-360, 1998
PubMed
5) Nakamura T, Kawagoe Y, Matsuda T, et al. : Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 1evels in acute respiratory distress syndrome patients. Blood Purif 22 : 256-260, 2004
 
6) Nakamura T, Sato E, Fujiwara N, et al. : Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients. J Crit Care 26 : 546-548, 2011
PubMed
7) Nakamura T, Sato E, Fujiwara N, et al. : Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem 44 : 601-604, 2011
PubMed
8) Chuah YK, Basir R, Talib H, et al. : Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases. Int J Inflam 2013 : 403460, 2013
PubMed
9) LeBlanc PM, Do99ett TA, Choi J, et al. : An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor. J Biol Chem 289 : 7777-7786, 2014
 
10) Nakamura T, Ebihara I, Shimada N, et al. : Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber. Int Care Med 24 : 1272-1276, 1998
 
11) Nakamura T, Kawagoe Y, Suzuki T, et al. : Changes of plasma interleukin-18 by direct hemoperfusion with polymyxin B-immobilized fiber in patients with septic shock. Blood Pur 23 : 417-420, 2005
 
12) Nakamura T, Suzuki Y, Shimada N, et al. : Hemoperfusion with polymyxin B-immobilized fiber attenuates the increased plasma levels of thrombomodulin and von Willebrand factor from patients with septic shock. Blood Purif 16 : 179-186, 1998
PubMed
13) Nakamura T, Ebihara I, Shoji H, et al. : Treatment with polymyxin B-immobilized fiber reduced platelet activation in septic shock patients : decrease in plasma ievels of soluble P-selectin, platelet factor-4 and beta-thromboglobulin. Inflamm Res 48 : 171-175, 1999
 
14) Liu XL, Wang XZ, Liu XX, et al. : Low-dose heparin as treatment for early disseminated intravascular coagulation during sepsis : A prospective clinical study. Exp Ther Med 7 : 604-608, 2013
PubMed
15) Choi Q, Hong KH, Kin J. E, et al. : Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation : high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection. Ann Lab Med 34 : 85-91, 2014
 
16) Iba T, Yamada A, Hashiguchi N, et al. : New therapeutic options for patients with sepsis and disseminated intravascular coagulation. Pol Arch Med Wewn, in press
 
17) Walkey AJ, Hammill BG, Curtis LH, et al. : Long term outcomes following development of new-onset atrial fibrillation during sepsis. Chest, in press
 
18) Nakamura T, Ushiyama C, Shoji H, et al. : Effect of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in sepsis patients undergoing hemodialysis. ASAIO J 48 : 41-44, 2002
PubMed
19) Nakamura T, Suzuki T, Kawagoe Y, et al. : Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic Peptide and brain natriuretic peptide levels in patients with septic shock, ASAIO J 54 : 210-213, 2008
PubMed
20) Antonucci E, Fiaccadori E, Donadello K, et al. : Myocardial depression in sepsis : From pathogenesis to clinical manifestations and treatment. J Crit Care 29 : 500-511, 2014
PubMed
21) Chen YX, Li CS : The prognostic and riskstratified value of heart-type fatty acid-binding protein in septic patients in the emergency department. J Crit Care 29 : 512-516, 2014
PubMed
22) Nakamura T, Kawagoe Y, Matsuda T, et al. : Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy. Blood Purif 21 : 282-286, 2003
PubMed
23) Yao B, Zhang LN, Ai YH, et al. : Serum S100β is a Better Biomarker than Neuron-Specific Enolase for Sepsis-Associated Encephalopathy and Determining Its Prognosis : A Prospective and Observational Study. Neurochem Res 39 : 1263-1269, 2014
 
24) Shimada N, Nakamura T, Shoji H, et al. : Hemoperfusion with polymyxin B-immobilized fiber reduces urinary podocyte numbers in patients with severe sepsis. Nephron 85 : 364-365, 2000
PubMed
25) Nakamura T, Ushiyama C, Suzuki Y, et al. : Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma. ASAIO J 48 : 244-248, 2002
PubMed
26) Nakamura T, Kawagoe Y, Matsuda T, et al. : Effects of polymyxin B immobilized fiber on urinary N-acetyl-beta-glucosaminidase in patients with severe sepsis. ASAIO J 50 : 563-567, 2004
PubMed
27) Nakamura T, Sugaya T, Node K, et al. : Urinary excretion of liver-type fatty acid-binding Protein in contrast medium-induced nephropathy. Am J Kidney Dis 47 : 439-444, 2006
PubMed
28) Nakamura T, Sugaya T, Koide H : Urinary liver-type fatty acid-binding Protein in septic shock : effect of polymyxin B-immobilized fiber hemoperfusion. Shock 31 : 454-459, 2009
PubMed
29) Doi K, Noiri E, Maeda-Mamiya R, et al. : Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med 38 : 2037-2042, 2010
PubMed
30) Norden AG, Lapsley M, Unwin RJ : Urine retinol-binding protein 4 : afunctional biomarker of the proximal renal tubule. Adv Clin Chem 63 : 85-122, 2014
 
31) Gomez H, Ince C, De Backer D, et al. : Aunified theory of sepsis-induced acute kidney injury : inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 41 : 3-11, 2014
PubMed
32) Sumi Y, Woehrie T, Chen Y, et al. : Plasma ATP is required for neutrophil activation in a mouse sepsis model. Shock, in press
 
33) Kim SJ, Choi J, Ryoo S, et al. : Interleukin-32γ transgenic mice resist LPS-mediated septic shock. J Microbiol Biotechnol, in press
 
34) Jiao J, Gao M, Zhang H, et al. : Identification of potential biomarkers by serum proteomics analysis in rats with sepsis. Shock 42 : 75-81, 2014
PubMed
35) Wen B, Combes V, Bonhoure A, et al. : Endotoxin-induced monocytic micoparticles have contrasting effects on endothelial inflammatory responses. PLoS One 9 : e91597, 2014
 
36) Kj eergaard AG, Rodgaard-Hansen S, Dige A, et al. : Monocytic expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients. PLoS One 9 : e92331, 2014
 
37) Mihajlovic DM, Lendak DF, Brikic SV, et al. : Endocan is useful biomarker of survival and severity in sepsis. Microvasc Res 93 : 92-97, 2014
 
P.13 掲載の参考文献
1) Glauser MP, Zanetti G, Baumgartner JD, et al. : Septic shock : pathogenesis. Lancet 338 : 732-736, 1991
PubMed
2) Wheeler AP, Bernard GR : Treating patients with severe sepsis. N Eng J Med 340 : 207-214, 1999
 
3) 小玉正智, 谷徹, 花澤一芳, 他 : エンドトキシン除去用ポリミキシンB固定化繊維充填カラム (PMX) の設計, 性能評価および臨床における有用性評価. 基礎と臨 28 : 1421-1432, 1994
Medical*Online
4) PMX治療検討委員会 : PMX多施設臨床評価-最終検討報告 (61症例) -. エンドトキシン血症救命治療研会誌 6 : 146-153, 2002
 
5) Wang Y, Liu Y, Sarker KP, et al. : Polymyxin B binds to anadamide and inhibits its cytotoxic effet. FEBS Lett 470 : 151-155, 2000
 
6) Kumagai T, Takeyama N, Yabuki T, et al. : Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock Shock 34 : 461-466, 2010
PubMed
7) Tsujimoto H, Ono S, Hiraki S, et al. : Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J Endotoxin Res 10 : 229-237, 2004
PubMed
8) Ono S, Tsujimoto H, Matsumoto A, et al. : Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg 188 : 150-156, 2004
PubMed
9) Kawamata T, Imaizumi H, Yoshida M, et al. : Polymyxin B-immobilized fiber improves hyperdynamic state in MRSA septic patients. Intensive Care Med 23 : 130-131, 1997
 
10) Tsushima K, Kubo K, Koizumi T, et al. : Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome. J Clin Apher 17 : 97-102, 2002
PubMed
11) 山下千鶴 : Septic ARDSに対してPMX-DHPが奏功した4症例. エンドトキシン血症救命治療研会誌 6 : 112-120, 2002
 
12) 山下千鶴, 藤川宝紀, 武智健一, 他 : PMX-DHP長時間施行の臨床効果に関する検討. ICUとCCU 29 : 557-566, 2005
Medical*Online
13) Seo Y, Abe S, Kurahara M, et al. : Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 45 : 1033-1038, 2006
PubMed
14) Mitaka C, Tsuchida N, Kawada K, et al. : A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Shock 32 : 478-483, 2009
PubMed
15) 山下千鶴, 池田寿昭, 高崎康史, 他 : PMX-DHP療法の施行時間に関する新たな戦略-2時間施行と長時間施行を比較して-. エンドトキシン血症救命治療研会誌 9 : 28-31, 2005
 
16) Nakamura T, Sato E, Fujiwara N, et al. : Suppression of high-mobility group box-l and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients. J Crit Care 26 : 546-549, 2011
 
17) Mitaka C, Fujiwara N, Yamamoto M, et al. : Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period. J Crit Care 29 : 728-732, 2014
PubMed
18) Vincent JL, Laterre PF, Cohen J, et al. : A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23 : 400-405, 2005
 
19) Cruz DN, Antonelli M, Fumagalli R, et al. : Early use of polymyxin B hemoperfusion in abdominal septic shock : The EUPHAS randomized controlled trial. JAMA 301 : 2445-2452, 2009
PubMed
20) Martin EL, Cruz DN, Monti G, et al. : Endotoxin removal : how far from the evidence? The EUPHAS 2 Proj ect. Contrib Nephrol 167 : 119-125, 2010
 
21) Klein DJ, Foster D, Schorr CA, et al. : The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock) : study protocol for a randomized controlled trial. Trials 15 : 218, 2014
 
22) Cantaluppi V, Assenzio B, Pasero D, et al. : Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 34 : 1638-1645, 2008
PubMed
23) Nishida O, Nakamura T, Kuriyama N, et al. : Sustained high-efficiency daily diafiltration using amediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis. Contrib Nephrol 173 : 172-181, 2011
PubMed
P.16 掲載の参考文献
1) Abe S, Azuma A, Mukae H, et al. : Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation : a multicenter retrospective analysis. Intern Med 51 : 1487-1491, 2012
PubMed
2) Abe S, Seo Y, Hayashi H, et al. : Neutrophil adsorption by polymyxin B-immobilized fiber column (PMX) for acute exacerbation in patients with interstitial pneumonia : a pilot study. Blood Purifi 29 : 321-326, 2010
 
3) Sato N, Kojima K, Horio Y, et al. : Successful treatment of severe amiodarone pulmonary toxicity with polymyxin B-immobilized fiber column direct hemoperfusion. Chest 143 : 1146-1150, 2013
PubMed
4) Yokoyama T, Tsushima K, Yamamoto H, et al. : Polymyxin B-immoblized fiber column hemoperfusion treatment for drug-induced severe respiratory failure : report of three cases. Inter Med 49 : 59-64, 2010
 
5) Takeda S, Munakata R, Abe S, et al. : Hypercytokinemia with 2009 influenza A (HINI) successfully treated with polymyxin B-immobilized fiber column hemoperfusion. Intensive Care Med 36 : 906-907, 2010
 
P.22 掲載の参考文献
1) Novitsky TJ : Limulus amebocyte lysate (LAL) detection of endotoxin in human blood. J Endotoxin Res 1 : 253-263, 1994
 
2) Jeukendrup AE, Vet-JooP K, Sturk A, et al. : Relationship between gastro-intestinal complaints and endotoxemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci 98 : 47-55, 2000
PubMed
3) Selkirk GA, McLellan TM, Wright HE, et al. : Mild endotoxemia, NF-kB translocation, and cytokine increase during exertional heat stress in trained and untrained individuals. Am J Physiol Regul Integr Comp Physiol 295 : R611-R623, 2008
PubMed
4) Brenchley JM, Price DA, Schacker TW, et al. : Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nature Medicine 12 : 1365-1371, 2006
PubMed
5) Basu S, Haghiac M, Surace P, et al. : Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity 19 : 476-482, 2011
 
6) Mclntyre CW, Harrison LEA, Eldehni MT, et al. : Circulating endotoxemia : A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 6 : 133-141, 2011
 
7) Erridge C, Attina T, Spickett CM, et al. : A high-fat meal induces low-grade endotoxemia : evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86 : 1286-1292, 2007
PubMed
8) Harte AL, Sabico S, Varma MC, et al. : High fat intake leads to acute postprandial exposure to circulating endotoxin in Type 2 diabetic subjects. Diabetes Care 35 : 375-382, 2012
PubMed
9) Levin J, Tomasulo PA, Oser RS : Detection of endotoxin in human blood and demonstration of an inhibitor. J Lab Clin Med 75 : 903-911, 1970
PubMed
10) Webster CJ : Principles of a quantitative assay for bacterial endotoxins in blood that uses Limulus Lysate and a chromogenic substrate. J Clin Microbiol 12 : 644-650, 1980
 
11) 土谷正和, 井上勝仁, 原田和明, 他 : ヒト血清アルブミンによる吸着したエンドトキシンの効果的な抽出. 防菌防黴誌 24 : 357-362, 1996
 
12) 稲田捷也, 遠藤厚重 : リムルス試薬を用いた血中エンドトキシンおよびβ-グルカン定量におけるカイネティック法での特異反応と非特異反応の判別. 医学と薬学 42 : 885-897, 1999
 
13) エンドトキシンーテストワコー添付文書, 和光純薬工業
 
14) 土谷正和 : エンドトキシン測定用をめぐる諸問題と展望. "エンドトキシン研究5研究と治療の進歩" 日本エンドトキシン研究会編. 医学図書出版, 2002, p17-24
 
15) Motoi Y, Oohashi T, Hirose H, et al. : Turbidimetric-kinetic assay of endotoxin in rumen fluid or serum of cattle fed rations containing various levels of rolled barley. J Vet Me Sci 55 : 19-25, 1993
PubMed
P.28 掲載の参考文献
1) USP. USP 30-NF 25, Bacterial Endotoxins Test (85). Rockville, MD : USP ; 2007
 
2) USP. USP 30-NF 25, Validation of Compendial Procedures (1225). Rockville, MD : USP ; 2007
 
3) FDA. Guidance for Industry Pyrogen and Endotoxins Testing : Questions and Answers : June 2012 Compliance
 
4) Levin J, Bang FB : Clottable protein in Limulus : its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 19 : 186-197, 1968
 
5) Iwanaga S : The limulus clotting reaction. Curr Opin Immunol 5 : 74-82, 1993
PubMed
6) Nakamura T, Morita T, Iwanaga S : Lipopolysac-charide-sensitive serine-protease zymogen (factor C) found in Limulus hemocytes. Isolation and characterization. Eur J Biochem 154 : 511-521, 1986
 
7) Muta T, Miyata T, Misumi Y, et al. : Limulus Factor C. An endotoxin-sensitive serine protease zymogen with a mosaic structure of complement-like, epidermal growth factor-like, and lectin-like domains. J Biol Chem 266 : 6554-6561, 1991
PubMed
8) Tokunaga F, Nakajima H, Iwanaga S : Further studies on lipopolysaccharide-sensitive serine protease zymogen (factor C) : its isolation from Limulus polyphemus hemocytes and identification as an intracellular zymogen activated by alpha-hymotrypsin, not by trypsin. J Biochem 109 : 150-157, 1991
 
9) Ding JL, Navas MA 3rd, Ho B : Two forms of factor C from the amebocytes of Carcinoscorpius rotundicauda : purification and characterization. Biochim Biophys Acta 1202 : 149-156, 1993
 
10) Ding J, Navas MA 3rd, Ho B : Molecular cloning and sequence analysis of factor C cDNA from the Singapore horseshoe crab, Carcinoscorpius rotundicauda. Mol Mar Biol Biotechnol 4 : 90-103, 1995
 
11) Ohno N, Emori Y, Yadomae T, et al. : Reactivity of Limulus amoebocyte lysate towards (1----3) -beta-D-Glucans. Carbohydr Res 207 : 311-318, 1990
PubMed
12) Pearson F, Bohon J, LeeW, et al. : Characterization of Limulus amoebocyte lysate-reactive material from hollow-fiber dialyzers. Appl Environ Microbiol 48 : 1189-1196, 1984
 
13) Chen L : Reckoning recombinant Factor C. Pharm Formulation Quality 7 : 58-60, 2006
 
14) FDA. Guideline on Validation of the Limulus Amebocyte Lysate Test as an End-product Endotoxin Test for Human and Animal Parenteral Drugs, Biological Products, and Medical Devices. Rockville, MD : FDA ; 1987
 
15) Bruce L, Barry S, Allen B : A Recombinant Factor C Procedure fbr the Detection of Gramnegative Bacterial Endotoxin. Pharmacopeial Forum 35 : 1613-1623, 2009
 
P.35 掲載の参考文献
1) Obata T, Nomura M, Kase Y, et al. : Early detection of the Limurus ameboocyte lysate reaction evoked by endotoxins, Anal Biochem 373 : 281-286, 2008
 
2) Shimizu T, Obata T, Sonoda H, et aL : Diagnostic potential of endotoxin scattering photometry for sepsos and septic shock. Shock 40 : 504-511, 2013
PubMed
3) Amar J, Burcelin R, Ruidavets J B, et al. : Energy intake is associated with endotoxicemia in apparently healthy men. Am J Clin Nutr 87 : 1219-1223, 2008
PubMed
4) 小幡徹, 清水智治, 谷徹, 他. : 高感度エンドトキシン測定ESP法を用いた透析液のエンドトキシン測定と培養検査の多施設比較. 腎と透析 75 別冊 : 122-124, 2013
 
P.40 掲載の参考文献
1) Bohuon C : A brief history of procalcitonin. Intensive Care Med 26 : S146-147, 2000
PubMed
2) Assicot M, Gendrel D, Carsin H, et al. : High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341 : 515-518, 1993
PubMed
3) Gendrel D, Bohuon C : Procalcitonin as a marker of bacterial infection. Pediatr lnfect Dis J 19 : 679-688, 2000
 
4) Dandonna P, Nix D, Wilson MF, et al. : Procalcitonin increases after endotoxin injection in normal subjects. J CIin Endocrinol Metab 79 : 1605-1608, 1994
 
5) Muller B, Becker KL, Schachinger H, et al. : Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28 : 977-983, 2000
 
6) Muller B, White JC, Nyl6n ES, et al. : Ubiquitous expression of the calcitonin-igene in multiple tissues in「esPonse to sepsis, J Clin Endocrinol Metab 86 : 396-404, 2001
 
7) Linscheid P, Seboek D, Nylen ES, et al. : In vitro and in vivo calcitonin-I gene expression in parenchymal cells : a novel product of human adipose tissue. Endocrinology 144 : 5578-5584, 2003
 
8) Harbarth S, Holeckova K, Froidevaux C, et al. : Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164 : 396-402, 2001
PubMed
9) Kumar A, Roberts D, Wood KE, et al. : Duration of hypotension before initiation of effective antimicrobial therapy is the critical determination of survival in human septic shock, Critical Care Med 34 : 1589-1596, 2006
PubMed
10) Bouadma L, Luyt CE, Tubach F, et al. : Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial) : a multicentre randomised controlled trial. Lancet 375 : 463-474, 2010
 
11) Schuetz P, Chiappa V, Briel M, et al. : Procalcitonin algorithms for antibiotic therapy decisions : a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 171, 1322-1331, 2011
PubMed
12) Aikawa N, Fujishima S, Endo S, et al. : Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother 11 : 152-159, 2005
PubMed
13) Endo S, Aikawa N, Fujishima S, et al. : Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis : a multicenter prospective study. J Infect Chemother 14 : 244-249, 2008
PubMed
14) Hergert-Rosenthal S, Marggraf G, Pietruck F, et al. : Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16, 975-979, 2001
 
15) Meisner M. 相川直樹監訳プロカルシトニン-生化学と臨床診断. UNI-MED Verlag. Bremen, 2010
 
16) Dellinger RP, Levy MM, Rhodes A, et al. : Surviving sepsis campaign : international guideline for management of severe sepsis and septic shock : 2012. Crit Care Med 41 : 580-637, 2013
PubMed
17) Dellinger RP, Levy MM, Carlet JM, et al. : Surviving Sepsis Campaign : international guide-line for management of severe sepsis and septic shock : 2008. Crit Care Med 34 : 17-60, 2008
 
18) 日本腹部救急医学会, 日本肝胆膵外科学会, 日本膵臓学会, 日本医学放射線学会編 : 急性膵炎診療ガイドライン 2010. 金原出版 2009
 
19) 日本集中治療医学会 : 日本版敗血症ガイドライン. 2012
 
20) 日本臨床腫瘍学会 : 発熱性好中球減少症 (FN) ガイドライン. 南江堂, 2012
 
P.47 掲載の参考文献
1) Sakaguchi S, Furusawa S : Oxidative stress and septic shock : metabolic of aspects of oxygenderived free radicals generated in the live during endotoxemia. FEMS Immunol Med Microbiol 47 : 167-177, 2006
 
2) Nolan JP : The role of intestinal endotoxin in liver injury : a long and evolving history. Hepatology 52 : 1829-1835, 2010
PubMed
3) Angulo P : Nonalcoholic fatty liver disease. N Engle J Med 346 : 1221-1231, 2002
 
4) Sakaguchi S, Takahashi S, Sasaki T, et al. : Progression of alcoholic and non-alcoholic steatohepatitis : common metabolic aspects of innate immune system and oxidative stress. Drug Metab Pharmacokinet 26 : 30-46, 2011
PubMed
5) Sakaguchi S, Furusawa S, Yokota K, et al. : Modification of tumor necrosis factor-induced acute toxicity D-galactosamine challenge by polymyxin B, an anti-endotoxin. Int J Immunopharmacol 22 : 935-942, 2000
PubMed
6) Bode C, Bod JC : Activation of the innate immune system and alcoholic liver disease : effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 29 : 166S-171S, 2005
PubMed
7) Vidali M, Hietala J, Occhino G, et al. : Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers. Free Radic Biol Med 45 : 306-311, 2008
 
8) Hayakawa T, Matsuzawa A, Noguchi T, et al. : The ASK-IMAP kinase pathways in immune and stress responses. Microbes Infect 8 : 1098-1107, 2006
 
9) 松沢厚, 一条秀憲 : ストレス応答キナーゼシグナルの破綻と疾患. 細胞工学 31 : 138-143, 2012
 
10) Day CP, James OF : Steatohepatitis : a tale of two "hits"? . Gastroenterology 114 : 842-845, 1998
PubMed
11) Wu D, Cederbaum AI : Oxidative stress mediated toxicity exerted by ethanol inducible CYP2E1. Toxicol Appl Pharmacol 207 : 70-76, 2005
PubMed
12) Lieber CS : Alcoholic fatty liver : its pathogenesis and mechanism of progression to inflammation and fibrosis, Alcohol 34 : 9-19, 2004
PubMed
13) 加藤眞三, 山岸由幸 : 酸化ストレスと薬物性肝障害. 医学のあゆみ 214, 877-881, 2005
Medical*Online
P.51 掲載の参考文献
1) Hisano Y, Nishi T, Kawahara A : The functional roles of S1P in immunity. J Biochem 152 : 305-311, 2012
PubMed
2) Liu Y, Wada R, Yamashita T, et al. : Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106 : 951-961, 2000
 
3) Allenda ML, Yamashita T, Proia RL : G-protein-coupled receptor S1P1 act within endothelial cells to regulate vascular maturation. Blood 102 : 3665-3667, 2003
 
4) Matloubian M, Lo CG, Cinamon G, et al. : Linphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 : 355-360, 2004
 
5) Vogel P, Donoviel MS, Read R, et al. : Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One 4 : e4112, 2009
PubMed
6) Cattoretti G, Mandelbaum J, Lee N, et al. : Targeted Disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res 69 : 8686-8692, 2009
PubMed
7) Green JA, Suzuki K, Cho B, et al. : The sphingosine 1-phosphate receptor S1P2, maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat Immunol 12 : 672-680, 2011
PubMed
8) Brinkmann V, Cyster JG, Hla T : FTY720 : sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4 : 1019-1025, 2004
PubMed
9) Iwasaki T, Tsunemi S, Kitano S, et al. : Role of sphingosine 1-phosphate signaling for the pathogenesis of autoimmune diseases. Inflammation and Regeneration 31 : 175-183, 2011
 
10) Nagahashi M, Hait NC, Maceyka M, et al. : Sphingosine-1-phosphate in chronic intestinal inflammation and cancer. Adv Biol Regul 54 : 112-120, 2014
PubMed
11) Keul P, Tolle M, Lucke S, et al. : The sphingosine-1-phosphate analogue FTY720 reduces athero-sclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 27 : 607-613, 2007
 
12) Kowalski GM, Carey AL, Selathurai A, et al. : Plasma Sphingosine-1-Phosphate Is Elevated in Obesity. PLoS One 8 : e72449, 2013
PubMed
13) Zabielski P, Baranowski M, Blachnio-Zabielska A, et al. : The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating eat liver. Prostaglandins Other Lipid Mediat 93 : 75-83, 2010.
 
14) Sattler K, Lehmann I, Graler M, et al. : HDL-Bound Sphingosine 1-Phosphate (S1P) Predicts the Severity of Coronary Artery Atherosclerosis. Cell Physiol Biochem 34 : 172-184, 2014
PubMed
15) Wang G, Kim RY, Imhof I, et al. : The immunosuppressant FTY720 prolongs survival in a mouse model of diet-induced coronary atherosclerosis and myocardial infarction. J Cardiovasc Pharmacol 63 : 132-143, 2014
 
16) Allende ML, Sipe LM, Tuymetova G, et al. : Sphingosine-1-phosohate phosphatase 1 regulates keratinocyte Differentiation and epidermal homeostasis. J Biol Chem 288 : 18381-18391, 2013
 
17) Suhuppel M, KUrschner U, Kleuser U, et al. : Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype, J Invest Dermatol 128 : 1747-1756, 2008
 
18) Schaper K, Dickhaut J, Japtok L, et al. : Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis. J Dermatol Sci 71 : 29-36, 2013
PubMed
P.55 掲載の参考文献
1) Akira S, Uematsu S, Takeuchi O : Pathogen recognition and innate immunity. Cell 124 : 783-801, 2006
PubMed
2) Kono DH, Baccala R, Theofilopoulos AN : TLRs and interferons : acentral paradigm in autoimmunity. Curr Opin Immunol 25 : 720-727, 2013
 
3) Saitoh S, Miyake K : Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol Rev 227 : 32-43, 2009
PubMed
4) Pisitkun P, Deane JA, DifilipPantonio MJ, et al. : Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312 : 1669-1672, 2006
PubMed
5) Christensen S, Shupe J, Nickerson K, et al. : Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 : 417-428, 2006
 
6) Ewald SE, Barton GM : Nucleic acid sensing Toll-like receptors in autoimmunity. Curr Opin Immunol 23 : 3-9, 2011
PubMed
7) Izui S, Iwamoto M, Fossati L, et al. : The Yaa gene model of systemic lupus erythematosus. Immunological reviews 144 : 137-156, 1995
PubMed
8) Lee PY, Kumagai Y, Li Y, et al. : TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 205 : 2995-3006, 2008
PubMed
9) Tabeta K, Hoebe K, Janssen EM, et al. : The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7and 9. Nature immunology 7 : 156-164, 2006
 
10) Kim YM, Brinkmann MM, Paquet ME, et al. : UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452 : 234-238, 2008
PubMed
P.59 掲載の参考文献
1) Adarme-Vega TC, Lim DK, Timmins M, et al. : Microalgal biofactories : a promising approach towards sustainable omega-3 fatty acid production. Microb Cell Fact 11 : 96, 2012
PubMed
2) de Jesus Raposo ME de Morais RM, de Morais AM : Health applications of bioactive compounds from marine microalgae. Life Sci 93 : 479-486, 2013
 
3) Adl SM, Simpson AG, Farmer MA, et al. : The new higher level classification of eukaryotes with emphasis on the taxonomy of protists. J Eukaryot Microbiol 52 : 399-451, 2005
PubMed
4) Jones SS : Chlorella. In "Health Bliss : 50 Revitalizing NatureFoods and Lifestyles Choices to Promote Vibrant Health" Read How You Want. com, 2010, p55-57
 
5) Queiroz ML, Bincoletto C, Valadares MC, et al. : Effects of Chlorella vulgaris extract on cytokines production in Listeria monocytogenes infected mice. Immunopharmacol Immunotoxicol 24 : 483-496, 2002
PubMed
6) Ibusuki K, Minamishima Y : Effect of Chlorella vulgaris extracts on murine cytomegalovirus infections. Nat Immun Cell Growth Regul 9 : 121-128, 1990
PubMed
7) Tanaka K, Yamada A, Noda K, et al. : A novel glycoprotein obtained from Chlorella vulgaris strain CK22 shows antimetastatic immunopotentiation. Cancer Immunol Immunother 45 : 313-320, 1998
PubMed
8) Konishi F, Tanaka K, Himeno K, et al. : Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE) : resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol Immunother 19 : 73-78, 1985
 
9) Wu LC, Ho JA, Shieh MC, et al. : Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. J Agric Food Chem 53 : 4207-4212, 2005
PubMed
10) Yamagishi S, Nakamura K, Inoue H : Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE) -related disorders. Med Hypotheses 65 : 953-955, 2005
PubMed
11) Hasegawa T, Matsuguchi T, Noda K, et al. : Toll-like receptor 2 is at least partly involved in the antitumor activity of glycoprotein from Chlorella vulgaris. Int Immunopharmacol 2 : 579-589, 2002
PubMed
12) Kraloveca JA, Meteraa KL, Kumara JR, et al. : Immunostimulatory principles from Chlorella pyrenoidosa--part 1 : isolation and biological assessment in vitro. Phytomedicine 14 : 57-64, 2007
 
13) Northcote DH, Goulding KJ, Horne RW : The chemical composition and structure of the cell wall of Chlorella pyrenoidosa. Biochem J 70 : 391-397, 1958
PubMed
14) White RC, Barber GA : An acidic polysaccharide from the cell wall of Chlorella pyrenoidosa. Biochim Biophys Acta 264 : 117-128, 1972
PubMed
15) Umezawa I, Komiyama K : Acidic polysaccharide CH-1 isolated from Chlorella pyrenoidosa and the use thereof. U. S. Patent 4533548, 1989
 
16) Suarez ER, Kralovec JA, Noseda MD, et al. : Isolation, characterization and structural determination of a unique type of arabinogalactan from an immunostimulatory extract of Chlorella pyrenoidosa. Carbohydr Res 340 : 1489-98, 2005
PubMed
17) Suarez ER, Kralovec JA, Grindley TB : Isolation of phosphorylated polysaccharides from algae : the immunostimulatory principle of Chlorella pyrenoidosa. Carbohydr Res 345 : 1190-1204, 2010
PubMed
18) Pugh N, Ross SA, ElSohly HN, et al. : Isolation of three high molecular weight polysaccharide preparations with potent immunostimulatory activity from Spirulina platensis, Aphanizomenon flos-aquae and Chlorella pyrenoidosa. Planta Med 67 : 737-742, 2001
PubMed
19) Hsu HY, Jeyashoke N, Yeh CH, et al. : Immunostimulatory bioactivity of algal polysaccharides from Chlorella pyrenoidosa activates macrophages via Toll-like receptor 4. J Agric Food Chem 58 : 927-936, 2010
PubMed
20) Cavacini, P : Soil algae from northern Victoria Land (Antarctica). Polar Bioscience 14 : 45-60, 2001
 
21) Broady PA : Taxonomic and ecological investigations of algae on steam-warmed soil on Mt Erebus, Ross Island, Antarctica. Phycologia 23 : 257-271, 1984
 
22) Ishida Y, Honda T, Mabuchi S, et al. : Validation of thermally assisted hydrolysis and methylationgas chromatography using a vertical microfurnace pyrolyzer for the compositional analysis of Fatty Acid components in microalgae. J Agric Food Chem 60 : 4222-4226, 2012
PubMed
23) Sun L, Jin Y, Dong L, et al. : The neuroprotective effects of Coccomyxa gloeobotrydiformis on the ischemic stroke in a rat model. Int J Biol Sci 9 : 811-817, 2013
 
24) Komatsu T, Kido N, Sugiyama T, et al. : Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection. Immunopharmacol Immunotoxicol 35 : 1-7, 2012
 
P.66 掲載の参考文献
1) Nagai Y, Akashi S, Nagafuku M, et al. : Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3 : 667-672, 2002
PubMed
2) Saitoh S, Akashi S, Yamada T, et al. : Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4) -MD-2 and ligand-induced TLR4 oligomerization. Int Immunol 16 : 961-969, 2004
PubMed
3) Kawai T, Adachi O, Ogawa T, et al. : Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 : 115-122, 1999
PubMed
4) Yamamoto M, Sato S, Hemmi H, et al. : Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 : 640-643, 2003
PubMed
5) Yamamoto M, Sato S, Hemmi H, et al. : Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420 : 324-329, 2002
PubMed
6) Yamamoto M, Sato S, Hemmi H, et al. : TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4 : 1144-1150, 2003
PubMed
7) Barton GM, Kagan JC : A cell biological view of Toll-like receptor function : regulation through compartmentalization. Nat Rev Immunol 9 : 535-542, 2009
PubMed
8) Kagan JC, Medzhitov R : Phosphoinositidemediated adaptor recruitment controls Toll-like receptor signaling. Cell 125 : 943-955, 2006
PubMed
9) Kagan JC, Su T, Horng T, et al. : TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat Immunol 9 : 361-368, 2008
 
10) Tanimura N, Saitoh S, Matsumoto F, et al. : Roles for LPS-dependent interaction and relocation of TLR4 and TRAM in TRIF-signaling. Biochem Biophys Res Commun 368 : 94-99, 2008
PubMed
11) West AP, Brodsky IE, Rahner C, et al. : TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 472 : 476-480, 2011
PubMed
12) Miller SI, Ernst RK, Bader MW : LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3 : 36-46, 2005
PubMed
13) Mata-Haro V, Cekic C, Martin M, et al. : The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 316 : 1628-1632, 2007
PubMed
14) Park BS, Song DH, Kim HM, et al. : The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458 : 1191-1195, 2009
PubMed
15) Hailman E, Lichenstein HS, Wurfel MM, et al. : Lipopolysaccharide (LPS) -binding Protein accelerates the binding of LPS to CD14. J Exp Med 179 : 269-277, 1994
PubMed
16) Haziot A, Ferrero E, K6ntgen F, et al. : Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4 : 407-414, 1996
 
17) Zanoni I, Ostuni R, Marek LR, et al. : CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 147 : 868-880, 2011
PubMed
18) Tanimura N, Saitoh S, Ohto U, et al. : The attenuated inflammation of MPL is due to the lack of CD14-dependent tight dimerization of the TLR4/MD2 complex at the plasma membrane. Int Immunol : 26 : 307-314, 2014
 
P.70 掲載の参考文献
1) Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee : American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference : definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 : 864-874, 1992
 
2) Ranieri VM, Thompson BT, Barie PS, et al. : Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366 : 2055-2064, 2012
PubMed
3) Opal SM, Latterre PF, Francois B, et al. : Effect of Eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis : the ACCESS randomized trial. JAMA 309, 1154-1162, 2013
 
4) Pierrakos C, Vincent JL : Sepsis biomarkers : a review. Crit Care 14 : R15, 2010
PubMed
5) Vincent JL, Marshall JC, Namendys-Silva SA, et al. : Assessment of the worldwide burden of critical illness : the Intensive Care Over Nations (ICON) audit. Lancet Respir Med 2 : 380-386, 2014
PubMed
6) Vincent JL, Sakr Y, Sprung CL, et al. : Sepsis in European intensive care units : results of the SOAP study. Crit Care Med 34 : 344-353, 2006
PubMed
7) Quenot Jp, Binquet C, Kara F, et al. : The Epidemiology of septic shock in French intensive care units : the prospective multicenter cohort EPISS study. Crit Care 17 : R65, 2013
PubMed
8) Fujishima S, Gando S, Saitoh D, et al. : A multicenter, prospective evaluation of quality of care and mortality in Japan based on the Surviving Sepsis Campaign guidelines. J Infect Chemother 20 : 115-120, 2014
PubMed
9) Zhou F, Peng Z, Murugan R, et al. : Blood purification and mortality in sepsis : a meta-analysis of randomized trials. Crit Care Med 41 : 2209-2220, 2013
PubMed
10) Marshall JC, Foster D, vincent JL, et al. : Diagnostic and prognostic implications of endotoxemia in critical illness : results of the MEDIC study. J Infect Dis 190 : 527-534, 2004
PubMed
11) Ikeda T, Ikeda K, Suda S, et al. : Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Innate Immun 2014 Jan7. [Epub ahead of print]
 
12) 小路久敬 : 血中エンドトキシン吸着材料の基本設計と性能評価. "敗血症の診断/治療の実状と病態・メカニズムをふまえた開発戦略". 技術情報協会, 2013, p241-246
 
13) Rheinhart K, Meier-Hellman A, Beale R, et al. : Open randomized phase H trial of an extracorporeal endotoxin adsorber in suspected Gramnegative sepsis. Crit Care Med 32 : 1662-1668, 2004
 
14) Bengsch S, Boos KS, Nagel D, et al. : Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis : clinical results of a pilot study. Shock 23 : 494-500, 2005
PubMed
15) Umgelter A, Reindl W, Lutz J, et al. : Treatment of septic patients with an arginine-based endotoxin adsorber column improves hemodynamics and reduces oxidative stress : results of a feasibility study. Blood Purif 26 : 333-339, 2008
PubMed
16) Ala-Kokko TI, Laurila J, Koskenkari J : A new endotoxin adsorber in septic shock : observational case series. Blood Purif 32 : 303-309, 2011
PubMed
17) 北山浩嗣, 和田尚弘, 山田昌由, 他 : PMX-05Rを使用した21症例の検討. エンドトキシン血症救命治療研会誌 13 : 128-130, 2009
 
18) 大木乃理子, 和田尚弘, 北山浩嗣, 他 : 超低出生体重児に対し低容量エンドトキシン吸着療法 (polymyxin-B immobilized column direct hemoperfusion) を施行した1例. 日児腎誌 26 : 99-104, 2013
 
19) Cruz DN, Antonelli M, Fumagalli R, et al. : Early use of polymyxin B hemoperfusion in abdominal septic shock : The EUPHAS randomized controlled trial. JAMA 301 2445-2452, 2009
PubMed
20) Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group : Polymyxin B hemoperfusion in clinical practice : the picture from an unbound collaborative registry. Blood Purif 37 (Suppl 1) : 22-25, 2014
 
21) Klein DJ, Foster D, Schorr CA, et al. : The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock) : study protocol for a randomized controlled trial. Trials 15 ; 218-232, 2014
 
P.75 掲載の参考文献
1) Miao EA, Rajan JV, Aderem A : Caspase-1-induced pyroptotic cell death. Immunol Rev 243 : 206-214, 2011
PubMed
2) Bergsbaken T, Fink SL, Cookson BT : Pyroptosis : host cell death and infiammation. Nat Rev Microbiol 7 : 99-109, 2009
 
3) Croker BA, O'Donnell JA, Gerlic M : Pyroptotic death storms and cytopenia. Curr Opin Immunol 26 : 128-137, 2014
PubMed
4) Hancock RE, Diamond G : The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8 : 402-410, 2000
PubMed
5) Nagaoka I, Hirota S, Niyonsaba F, et al. : Cathelicidin family of antibacterial peptides CAP18 and CAPll inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14 (+) cells. J Immunol 167 : 3329-3338, 2001
 
6) Pochet S, Tandel S, Querriere S, et al. : Modulation by LL-37 of the responses of salivary glands to purinergic agonists. Mol Pharmacol 69 : 2037-2046, 2006
PubMed
7) Hu Z, Murakami T, Suzuki K, et al. : Antimicrobial cathelicidin peptide LL-37 inhibits the LPS/ATP-induced pyroptosis of macrophages by dual mechanism. PLoS One 9 : e85765, 2014
PubMed
8) Nagaoka l, Tamura H, Hirata M : An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J Immunol 176 : 3044-3052, 2006
 
9) Suzuki K, Murakami T, Kuwahara-Arai K, et al. : Human anti-microbial cathelicidin peptide LL-37 suppresses the LPS-induced apoptosis of endothelial cells. Int Immunol 23 : 185-193, 2011
PubMed
P.78 掲載の参考文献
1) Dellinger RP, Levy MM, Rhodes A, et al. : Surviving sepsis campaign : international guide-lines for management of severe sepsis and septic shock : 2012. Crit Care Med 41 : 580-637, 2013
 
2) Berkowitz DM, Danai PA, Eaton S, et al. : Accurate characterization of extravascular lung water in acute respiratory distress syndrome. Crit Care Med 36 : 1803-1809, 2008
PubMed
3) Khwannimit B, Bhurayanontachai R : Prediction of fluid responsiveness in septic shock patients : comparing stroke volume variation by Flo Trac/Vigileo and automated pulse pressure variation. Eur J Anaesthesiol 29 : 64-69, 2012
 
4) Ritter S, Rudiger A, Maggiorini M : Transpulmonary thermodilution-derived cardiac function index identifies cardiac dysfunction in acute heart failure and septic patients : an observational study. Crit Care 13 : R133, 2009
PubMed
5) Chew MS, Ihrman L, During J, et al. : Extravascular lung water index improves the diagnostic accuracy of lung injury in patients with shock. Crit Care 16 : R1, 2012
PubMed
6) 平泰彦, 高松由佳, 田北無門, 他 : 重症病態における肺経由動脈熱希釈法 (TPTD) で計測される血管内容量 (GEDV, ITBV), 肺血管外水分量 (EVLW), 肺血管透過性指数 (PVPI) の意義. 日臨麻会誌 33 : 254-262, 2013
Medical*Online
7) Maeder M, Fehr T, Rickli H, et al. : Sepsis-associated myocardial dysfunction : diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129 : 1349-1366, 2006
PubMed
8) Parrillo JE, Parker MM, Natanson C, et al. : Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113 : 227-242, 1990
PubMed
9) Kumar A, Thota V, Dee L, et al. : Tumor necrosis factor alpha and interleukin lbeta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183 : 949-958, 1996
 
10) http://www.tokibo.co.jp/products/pcr_hm/detail/126.html
 
11) http://jp.edwards.com/professionals/products/hemodynamic_monitoring/monitors/vigileo/
 
P.84 掲載の参考文献
1) Miyake K : Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2. Trends Microbio 4 : 186-192, 2004
 
2) Asl MN, Hosseinzadeh H : Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 22 : 709-724, 2008
PubMed
3) Kakegawa H, Matsumoto H, Satoh T : Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-allergic actions. Chem Pharm Bull 40 : 1439-1442, 1992
PubMed
4) Kim JK, Oh SM, Kwon HS, et al. : Anti-inflammatory effect of roasted licorice extracts on lipopolysaccharide-induced inflammatory responses in murine macrophages, Biochem Biophys Res Commun 345 : 1215-1223, 2006
PubMed
5) Takahashi T, Takasuka N, Iigo M, et al. : Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci 95 : 448-453, 2004
PubMed
6) Kim JY, Park SJ, Yun KJ, et al. : Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264. 7macrophages. Eur J pharmacol 584 : 175-184, 2008
 
7) Schrofelbauer B, Raffetseder J, Hauner M, et al. : Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochem J 421 : 473-482, 2009
PubMed
8) Park SJ, Youn HS : SupPression of homodimerization of toll-like receptor 4 by isoliquiritigenin. Phytochemistry 71 : 1736-1740, 2010
PubMed
9) Honda H, Nagai Y, Matsunga T, et al. : Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. J Leukoc Biol 91 : 967-976, 2012
 
10) Kim HM, Park BS, Kim JI, et al. : Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130 : 906-917, 2007
PubMed
11) Youn HS, Kim YS, Park ZY, et al. : Sulforaphane suppresses oligomerization of TLR4 in a thioldependent manner. J Immunol 184 : 411-419, 2009
 
12) Schmitz G, Ors6 E : CD14 signalling in lipid rafts : new ligands and co-receptors. Curr Opin Lipidol 13 : 513-521, 2002
 
13) Kumar S, Sharma A, Madan B, et al. : Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells. Biochem Pharmacol 73 : 1602-1612, 2007
PubMed
14) Youn HS, Lim HJ, Lee HJ, et al. : Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-like receptor 4 dimerization. Biosci Biotechnol Biochem 72 : 368-375, 2008
PubMed
15) Kim JH, Jeong JH, Jeon ST, et al. : Decursin inhibits induction of inflammatory mediators by blocking nuclear factor-kappaB activation in macrophages. Mol Pharmacol 69 : 1783-1790, 2006
PubMed
16) Kanuri G, Weber S, Volynets V, et al. : Cinnamon extract protects against acute alcohol-induced Iiver steatosis in mice. J Nutr 139 : 482-487, 2009
 
17) Willis LM, Bielinski DF, Fisher DR, et al. : Walnut extract inhibits LPS-induced activation of BV-2 microglia via internalization of TLR4 : possible involvement of phospholipase D2. Inflammation 33 : 325-333, 2010
PubMed
18) Rhule A, Rase B, Smith JR, et al. : Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginseng. J Ethnopharmacol 116 : 179-186, 2008
PubMed
19) Yu T, Ahn HM, Shen T, et al. : Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans. J Ethnopharmacol 137 : 1197-1206, 2011
 
20) Lian LH, Jin X, Wu YL, et al. : Hepatoprotective effects of Sedum sarmentosum on D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. J pharmacol Sci 114 : 147-157, 2010
 
21) Youn HS, Lee JK, Choi YJ, et al. : Cinnamaldehyde suppresses Toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem Pharmacol 75 : 494-502, 2008
PubMed
22) Youn HS, Saitoh SI, Miyake K, et al. : Inhibition of homodimerization of Toll-like receptor 4 by curcumin Biochem. Pharmacol 72 : 62-69, 2006
PubMed
23) Gradisar H, Keber M, Pristovsek P, et al. : MD-2 as the target of curcumin in the inhibition of response to LPS. J Leukoc Biol 82 : 968-974, 2007
PubMed
24) Park SH, Kyeong MsS, Hwang Y, et al. : Inhibition of LPS binding to MD-2 co-receptor for suppressing TLR4-mediated expression of inflammatory cytokine by 1-dehydro-10-gingerdione from dietary ginger. Biochem Biophys Res Commun 419 : 735-740, 2012
 
25) Youn HS, Lee JY, Saitoh SI, et al. : Suppression of MyD88-and TRIF-dependent signaling pathways of toll-like receptor by (-) -epigallocatechin-3-gallate, a polyphenol component of green tea. Biochem Pharmacol 72 : 850-859, 2006
PubMed
26) Huang H, Cheng Z, Shi H, et al. : Isolation and characterization of two flavonoids, engeletin and astilbin, from the leaves of Engelhardia rox-burghiana and their potential anti-inflammatory properties. J Agric Food Chem 59 : 4562-4569, 2011
 
27) Remichkova M, Dimitrova P, Philipov S, et al. : Toll-like receptor-mediated anti-inflammatory action of glaucine and oxoglaucine. Fitoterapia 80 : 411-414, 2009
PubMed
28) Lyss G, Knorre A, Schmidt TJ, et al. : The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65. J Biol Chem 273 : 33508-33516, 1998
PubMed
29) Kim YJ, Jang ER, Lee JC, et al. : Diarylheptanoid hirsutenoxime inhiblts toll-like receptor 4-mediated NF-kappaB activation regulated by Akt pathway in keratinocytes. Am J Chin Med 38 : 1207-1222, 2010
PubMed
30) Huang H, Chang EJ, Lee Y, et al. : Agenomewide microarray analysis reveals anti-inflammatory target genes of paeonol in macrophages. Inflamm Res 57 : 189-198, 2008
 
31) Ahn SI, Lee JK, Youn HS : Inhibition of homodimerization of Toll-like receptor 4 by 6-shogaol. Mol Cells 27 : 211-215, 2009
PubMed
32) Park SJ, Lee MY, Son BS, et al. : TBK1-targeted suppression of TRIF-dependent signaling pathway of Toll-like receptors by 6-shogaol, an active component of ginger. Biosci Biotechnol Biochem 73 : 1474-1478, 2009
PubMed
33) Liang Q, Wu Q, Jiang J, et al. : Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties. J Biol Chem 286 : 26470-26479, 2011
 
34) Chiou WF, Chen CC, Lin IH, et al. : 1, 3, 5-trihydroxy-4-prenylxanthone represses lipopolysaccharide-induced iNOS expression via impeding posttranslational modification of IRAK-1. Biochem Pharmacol 81 : 752-760, 2011
PubMed
35) Peri F, Calabrese V : Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds : an Update. J Med Chem 57 ; 3612-3622, 2014
PubMed
36) Steward A, Christian RA, Hamilton KO, et al. : Co-administration of polyanions with a phosphorothioate oligodeoxynucleotide (CGP 69846A) : a role for the scavenger receptor in its in vivo disposition. Biochem Pharmacol 56 : 509-516, 1998
PubMed
P.88 掲載の参考文献
1) Koide N, Abe K, Narita K, et al. : A poptotic cell death of vascular endothelial cells and renal tubular cells in the generalized Shwartzman reaction. FEMS Immunol Med Microbiol 31 : 205-211, 1996
 
2) Koide N, Morikawa A, Odkhuu E, et al. : Low susceptibility of NC/Nga mice to the lipopolysaccharide-mediated lethality with D-galactosamine sensitization and the involvement of fewer natural killer T cells. Innate Immun 18 : 35-43, 2012
 
3) Koide N, Morikawa A, Tumurkhuu G, et al. : Lipopolysaccharide and interferon-gamma enhance Fas-mediated cell death in mouse vascular endothelial cells via augmentation of Fas expression. Clin Exp Immunol 150 : 553-560, 2007
PubMed
4) Morikawa A, Koide N, Kato Y, et al. : Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 68 : 6209-6214, 2000
 
5) Koide N, Mu MM, Hassan F, et al. : Lipopolysaccharide enhances interferon-gamma-induced nitric oxide (NO) production in murine vascular endothelial cells via augmentation of interferon regulatory factor-1 activation. J Endotoxin Res 13 : 167-175, 2007
PubMed
6) Tsolmongyn B, Koide N, Jambalganiin U, et al. : A Toll-like receptor 21igand, Pam3CSK4, augments interferon-γ-induced nitric oxide production via a physical association between MyD88 and interferon-γ receptor in vascular endothelial cells. Immunology 140 : 352-361, 2013
 
P.93 掲載の参考文献
1) Ohno N, Uchiyama M, Tsuzuki A, et al. : Solubilization of yeast cell-wall beta- (1-->3) -D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr Res 316 : 161-172, 1999
PubMed
2) 大野尚仁 : βグルカンの生体防御系修飾作用. 日細菌誌 55 : 527-537, 2000
Medical*Online
3) Inoue K, Takano H, Koike E, et al. : Candida soluble cell wall beta-glucan facilitates ovalbumin-induced allergic airway inflammation in mice : Possible role of antigen-presenting cells. Respir Res 10 : 68, 2009
PubMed
P.97 掲載の参考文献
1) Jansen T, Daiber A : Direct Antioxidant Properties of Bilirubin and Biliverdin. Is there a Role for Biliverdin Reductase? Front Pharmacol 3 : 30, 2012
 
2) Fondevila C, Shen XD, Tsuchiyashi S, et al. : Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40 : 1333-1341, 2004
PubMed
3) Nakao A, Otterbein LE, Overhaus M, et al. : Biliverdin protects the functionai integrity of a transplanted syngeneic small bowel. Gastroenterology 127 : 595-606, 2004
 
4) Deguchi K, Hayashi T, Nagotani S, et al. : Reduction of cerebral infarction in rats by biliverdin associated with amelioration of oxidative stress. Brain Res 1188 : 1-8, 2008
PubMed
5) Sarady-Andrews JK, Liu F, Gallo D, et al. : Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 289 : L1131-1137, 2005
PubMed
6) Kosaka J, Morimatsu H, Takahashi T, et al. : Effects of biliverdin administration on acute lung injury induced by hemorrhagic shock and resuscitation in rats. PLoS One 8 : e63606, 2013
PubMed
7) Morimatsu H, Takahashi T, Shimizu H, et al. : Heme proteins, Heme Oxygenase-1 and Oxidative stress. In "Oxidative Stress-Molecular Mechanisms and Biological Effects", eds Lushchak V, Semchyshyn HM, InTech-Open Access Publisher, Rijeka, Croatia, 2012, p109-124
 
P.102 掲載の参考文献
1) Pellati D, Mylonakis I, Bertoloni G, et al. : Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol 140 : 3-11, 2008
PubMed
2) Kajihara T, Okagaki R, Ishihara O : LPS-induced transient testicular dysfunction accompanied by apoptosis of testicular germ cells in mice. Med Mol Morphol 39 : 203-208, 2006
PubMed
3) Demir A, TOrker P, Onol FF, et al. : Effect of experimentally induced Escherichia coli epididymo-orchitis and ciprofloxacin treatment on rat spermatogenesis. Int J Urol 14 : 268-272, 2007
 
4) SchupPe HC, Meinhardt A, Allam Jp, et al. : Chronic orchitis : aneglected cause of male infertility? Andrologia. 40 : 84-91, 2008
 
5) Beale R, Reinhart K, Brunkhorst FM, et al. : Promoting Global Research Excellence in Severe Sepsis (PROGRESS) : lessons from an internationai sepsis registry. Infection 37 : 222-232, 2009
 
6) 厚生労働省大臣官房統計情報部 : 平成26年 我が国の人口動態 平成24年までの動向. 1-59, 2014
 
7) Aoyama M, Kotani J, Usami M : Gender difference in granulocyte dynamics and apoptosis and the role of IL-18 during endotoxin-induced systemic inflammation. Shock 32 : 401-409, 2009
PubMed
8) Nakanishi K, Yoshimoto T, Tsutsui H, et al. : Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19 : 423-474, 2001
 
9) Zhang H, Hile KL, Asanuma H, et al. : IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism. Am J Physiol Renal Physiol. 301 : F171-178, 2011
PubMed
10) Abu Elhija M, Lunenfeld E, Eldar-Geva T, et al. : Over-expression of IL-18, ICE and IL-18 R in testicular tissue from sexually immature as compared to mature mice. Eur Cytokine Netw 19 : 15-24, 2008
 
11) Strand ML, Wahlgren A, Svechnikov K, et al. : Interleukin-18 is expressed in rat testis and may promote germ cell growth. Mol Cell Endocrinol 240 : 64-73, 2005
PubMed
12) Komsky A, Huleihel M, Ganaiem M, et al. : Presence of IL-18 in testicular tissue of fertile and infertile men. Andrologia 44 : 1-8, 2012
PubMed
13) Abu Elhija M, Lunenfeld E, Huleihel M : LPS increases the expression levels of IL-18, ICE and IL-18 R in mouse testes. Am J Reprod Immunol 60 : 361-371, 2008
PubMed
14) Tripathi R, Mishra DP, Shaha C : Male germ cell development : turning on the apoptotic pathways. J Reprod Immunol 83 : 31-35, 2009
PubMed
15) Tourneur L, Chiocchia G : FADD : a regulator of life and death. Trends Immunol 31 : 260-269, 2010
PubMed
16) Snyder CM, Shroff EH, Liu J, et al. : Nitric oxide induces cell death by regulating anti-apoptotic BCL-2 family members. PLoS One 4 : e7059, 2009
PubMed
17) Tsujimoto Y : Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195 : 158-167, 2003
PubMed
18) Su SH, Jen CJ, Chen HI : NO signaling in exercise training-induced anti-apoptotic effects in human neutrophils. Biochem Biophys Res Commun 405 : 58-63, 2011
PubMed
19) Bamias G, Corridoni D, Pizarro TT, et al. : New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation. Cytokine 59 : 451-459, 2012
PubMed
P.105 掲載の参考文献
1) 小幡徹 : 臨床試料における新しい高感度ET測定法. 日血栓止血会誌 20 : 66-71, 2009
 
2) 清水智治, 小幡徹, 赤堀浩也, 他 : Endotoxin scattering photometory (ESP) 法による血中ET測定の現状と課題. 日本エンドトキシン・自然免疫研究会編, エンドトキシン・自然免疫研究 15. 医学図書出版, 2012, p31-34
 
3) Obata T, Nomura M, Kase Y, et al. : Early detection of the Limulus amebocyte lysate reaction evoked by endotoxins. Anal Biochem 373 : 281-286, 2008
PubMed
4) Shimizu T, Obata T, Sonoda H, et al. : Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock. Shock 40 : 504-511, 2013
PubMed
5) Shimizu T, Obata T, Sonoda H, et al. : The ability of endotoxin adsorption during a Ionger duration of direct hemoperfusion with a polymyxin B-immobilized fiber column in patients with septic shock. Transfus Apher Sci 49 : 499-503, 2013
 

書評

最近チェックした商品履歴

Loading...